Table 1 Number of people in the study with each immune-mediated disease, and percentage who were female
Immune-mediated diseases (ICD-10 codes) | England, 1999 – 2011 | |
|---|---|---|
N | % of females | |
Addison’s disease (E27) | 11 839 | 59 |
Ankylosing spondylitis (M45) | 29 136 | 30 |
Autoimmune haemolytic anaemia (D59.1) | 9 241 | 54 |
Chronic active hepatitis (K73.2) | 4 439 | 70 |
Coeliac disease (K90) | 70 715 | 67 |
Crohn’s disease (K50) | 125 240 | 56 |
Dermatomyositis (M33.0-M33.1) | 2 768 | 67 |
Diabetes mellitus (E10) | 426 471 | 46 |
Goodpasture’s syndrome (M31) | 1 058 | 49 |
Hashimoto’s thyroiditis (E06.3) | 8 630 | 90 |
Idiopathic thrombocytopenia purpura (D69) | 31 043 | 55 |
Multiple sclerosis (G35) | 82 256 | 69 |
Myasthenia gravis (G70) | 11 279 | 49 |
Myxoedema (E03.8–E03.9) | 938 696 | 81 |
Pemphigoid (L12) | 13 642 | 56 |
Pemphigus (L10) | 2 348 | 56 |
Pernicious anaemia (D51.0) | 67 890 | 68 |
Polyarteritis nodosa (M30.0) | 2 249 | 44 |
Polymyositis (M33.2) | 3 860 | 62 |
Primary biliary cirrhosis (K74) | 11 146 | 84 |
Psoriasis (L40) | 119 454 | 48 |
Rheumatoid arthritis (M05–M06) | 331 393 | 71 |
Scleroderma (M34) | 11 494 | 82 |
Sjogren’s syndrome (M35.0) | 17 741 | 89 |
Systemic lupus erythematosus (M32) | 25 576 | 86 |
Thyrotoxicosis (E05) | 132 826 | 79 |
Ulcerative colitis (K51) | 180 397 | 49 |